Dr. Mark Babizhayev PHD

Dr. Babizhayev is a bio-physicist, achieving a Ph.D. in Biophysics and Pathophysiology. He dedicated many years to scientific research, principally at the Helmholtz Research Institute of Eye Disease, in Moscow. During that time, he accumulated over 86 published articles and also has 15 patents to his name. He is also a principal involved in the development of a breakthrough for the treatment and prevention of senile cataracts. Dr. Babizhayev presented for the first time to a Western audience as a keynote speaker at the 2002 AACL Anti-Aging Conference of London held in Monte Carlo.

Dr. Mark Babizhayev's academic and professional timeline is as follows:

• 1982: Graduated from the 2nd Moscow Medical Institute (Pirogov’s) with a degree in doctor-biophysics.
• 1988: Earned a Ph.D. in Biophysics and Pathophysiology at the Moscow Helmholtz Research Institute of Eye Diseases, Moscow, Russian Federation.
• 1992: Received the Oka Memorial Award in Yokohama, Japan.
• 1994: Granted by the International Science Foundation, Helmoltz Research Institute of Moscow.
• 2001: Mentioned the testing of NAC anti-cataract eye drops in animals, particularly in canines with age-related cataracts.
• 2003: Discussed the development of a precise product with N-acetylcarnosine, emphasizing the importance of specific impurity levels.
• Current Positions: Dr. Babizhayev serves as the Executive Director of Innovative Vision Products, Inc. in Wilmington, Delaware, USA, and as a Senior Research Investigator at the Moscow Helmholtz Research Institute of Eye Diseases (RF). He also acts as a Scientific Consultant to Exsymol SAM in Monte Carlo, Monaco.